FACT-CTTC Quality Boot Camp, CTTC 2024

Quality Boot Camp Presenters

Ed Brindle

Ed Brindle MSc, MLT
QA Manager - CTT Program, Hamilton Health Sciences, Ontario 

Edwin Brindle is the Quality Manager at Hamilton Health Sciences, Cellular Therapy and Transplantation. Ed has over 30 years’ experience as a Medical Lab Technologist in Hematology, Transfusion, Microbiology, Clinical Biochemistry, Quality Management, Cord Blood and Cellular Therapy and has served in various Technical and Managerial roles within UK and Canada. He is currently the Quality Manager for the Cellular Therapy & Transplantation Service at The Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Ontario, Canada.

He serves as a member of the FACT HPC Standards and Quality Management Committee; Canadian Society for Medical Lab Science; Canadian Standards Association (CSA) and actively participates on the BMT and Cellular Therapy Laboratory National Standards. Ed continues to be an advocate for quality and loves to share his passion for continuous quality improvement to enable facilities to succeed in meeting International Regulatory and accreditation Standards.

Susie Joron

Susie Joron, BS
Manager, Héma-Québec Donor & Cord Blood Registry

Susie Joron serves as the Operations Manager at Hema-Quebec in Montreal, QC, where she has significantly contributed since 2013, particularly in developing the stem cell donor and cord blood services. She holds a BSc in Microbiology and is pursuing an Executive MBA from Laval University in Quebec City, QC. Her areas of expertise include process development, strategic planning, quality & regulations, and operational efficiency.

With over 15 years of experience in the field of cellular therapy, Susie has also held key roles in stem cell transplant programs across Canada. Her responsibilities have encompassed the management of activities such as stem cell donor selection, recruitment, eligibility, and collection, as well as the importation of stem cell products. She has been instrumental in establishing international partnerships with the World Marrow Donor Association (WMDA) and its members. Recently, she became an inspector for the Foundation for the Accreditation of Cellular Therapy (FACT). Additionally, Susie is an active board member at the Swab The World Foundation.

Harminder Kaur-Singh

Harminder Kaur-Singh Bsc, BA, SSGB, CPHQ (HOST)
Quality Advisor, Cellular Therapy Program at CHU Sainte-Justine

Harminder Kaur-Singh is an accomplished professional with over 15 years of experience in regulatory compliance and quality improvement in the field of cell therapy. Harminder is a certified LEAN Green Belt and CPHQ, with extensive experience leading regulatory compliance and improvement efforts as both an employee and a consultant.

In her current role as Quality Advisor for the Stem Cell transplant program at CHU Sainte-Justine in Montréal, Quebec she  works with all cell therapy sectors to ensure regulatory compliance and quality improvement efforts.

Currently, Harminder serves as the Director-at-Large for Quality for the CTTC (Cell Therapy Transplant Canada), and also co-chairs the Quality & Regulatory Committee for the CTTC. Harminder also is a member of the FACT Education Committee.

Nic Prokopishyn

Nic Prokopishyn, PhD (HOST)
Cellular Therapy Lab Director, Alberta Blood and Marrow Transplant Program

Dr. Nicole Prokopishyn is currently serving as the Cellular Therapy Lab Director at the Alberta Blood and Marrow Transplant Program: Foothills Medical Centre, Alberta Children’s Hospital, Tom Baker Cancer Centre, and Calgary Laboratory Services. In this role, she oversees the provision of services for adult and pediatric transplants and cellular therapy. Nicole obtained her PhD in Biochemistry from the University of Saskatchewan. After completing her studies, she spent 10 years working abroad, with 5 years in Houston and 5 years in Philadelphia. During her time in these locations, she focused on the development of gene editing technologies in blood stem cells for the treatment of sickle cell disease and hemophilia. Nicole returned to Canada and accepted the director role at the Alberta Blood and Marrow Transplant Program, combining her expertise in quality assurance with a passion for treating patients through transplant and cellular therapy. Throughout her career, she has written numerous articles and presented her research findings internationally in the field of Cellular Therapy. Currently, she serves as the Chair of FACT's Standards Development Committee. In this role, she contributes to the development and enhancement of quality standards in this specialized field. Dr. Prokopishyn's extensive experience, dedication to improving patient outcomes, and commitment to advancing knowledge in the field make her one of the leading authorities in Cellular Therapy. Dr. Prokopishyn has been a FACT Inspector since 2013.